Abstract
Resolution of ternary and quaternary mixtures of paracetamol (PAR), desxtromethorphan (DEX), phenylephrine (PHE), and chlorpheniramine (CHL) was successfully achieved with minimum sample pre-treatment and without analyte separation using a rapid method based on partial least squares (PLS) and UV spectral data. Multivariate PLS calibration was performed using 35 ternary and quaternary mixtures and the model was employed for prediction of analyte in 15 external test samples. Simultaneous determination of the analytes was possible by analyzing absorbances between 210 and 300 nm. Q2 values which are a measure of the predictivity of the PLS models were between 0.9696 and 0.9880 in ternary mixtures and between 0.9230 and 0.9757 in quaternary mixtures. The PLS models were successfully applied to determine the analytes in real pharmaceutical preparations. The mean recoveries for the analytes in the real samples were between 95.25 and 102.4% in ternary and between 93.52 and 103.55% in quaternary mixtures.
Keywords: Chlorpheniramine, dextromethorphan, paracetamol, phenylephrine, partial least squares, pharmaceutical
Current Pharmaceutical Analysis
Title:Simultaneous Determination of Paracetamol, Dextromethorphan, Phenylephrine and Chlorpheniramine Using Partial Least Squares
Volume: 9 Issue: 2
Author(s): Masoud Shariati-Rad, Mohsen Irandoust, Niloufar Amin and Farhad Ahmadi
Affiliation:
Keywords: Chlorpheniramine, dextromethorphan, paracetamol, phenylephrine, partial least squares, pharmaceutical
Abstract: Resolution of ternary and quaternary mixtures of paracetamol (PAR), desxtromethorphan (DEX), phenylephrine (PHE), and chlorpheniramine (CHL) was successfully achieved with minimum sample pre-treatment and without analyte separation using a rapid method based on partial least squares (PLS) and UV spectral data. Multivariate PLS calibration was performed using 35 ternary and quaternary mixtures and the model was employed for prediction of analyte in 15 external test samples. Simultaneous determination of the analytes was possible by analyzing absorbances between 210 and 300 nm. Q2 values which are a measure of the predictivity of the PLS models were between 0.9696 and 0.9880 in ternary mixtures and between 0.9230 and 0.9757 in quaternary mixtures. The PLS models were successfully applied to determine the analytes in real pharmaceutical preparations. The mean recoveries for the analytes in the real samples were between 95.25 and 102.4% in ternary and between 93.52 and 103.55% in quaternary mixtures.
Export Options
About this article
Cite this article as:
Shariati-Rad Masoud, Irandoust Mohsen, Amin Niloufar and Ahmadi Farhad, Simultaneous Determination of Paracetamol, Dextromethorphan, Phenylephrine and Chlorpheniramine Using Partial Least Squares, Current Pharmaceutical Analysis 2013; 9 (2) . https://dx.doi.org/10.2174/1573412911309020009
DOI https://dx.doi.org/10.2174/1573412911309020009 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Thrombolysis for Acute Ischemic Stroke
Current Topics in Medicinal Chemistry Current Status and Challenges in Rotigotine Delivery
Current Pharmaceutical Design Designing of Selective γ-Secretase Inhibitory Benzenesulfonamides through Comparative In Vitro and In Silico Analysis
Current Drug Discovery Technologies Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia
Current Pharmaceutical Design Diagnosing and Treating Catatonia: An Update
Current Psychiatry Reviews The Implications of Autophagy in Alzheimer’s Disease
Current Alzheimer Research Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives
Current Stem Cell Research & Therapy Neurodegenerative Diseases of the Retina and Potential for Protection and Recovery
Current Neuropharmacology Fluoxetine and all other SSRIs are 5-HT<sub>2B</sub> Agonists - Importance for their Therapeutic Effects
Current Neuropharmacology Commentary (Research Highlights: Wnt-Signalling: A New Direction for Alzheimer Disease?)
CNS & Neurological Disorders - Drug Targets Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit
Current Neurovascular Research Dantrolene : From Malignant Hyperthermia to Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets HIV-1 Vpu Interference with Innate Cell-mediated Immune Mechanisms
Current HIV Research Comparison of Radiohaloanalogues of Meta-Iodobenzylguanidine (MIBG) for a Combined Gene- and Targeted Radiotherapy Approach to Bladder Carcinoma
Medicinal Chemistry Structure and Function of Fbxo7/PARK15 in Parkinson's Disease
Current Protein & Peptide Science Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis
Current Neuropharmacology Endogenous Cannabinoid and Opioid Systems and their Role in Nicotine Addiction
Current Drug Targets Tianeptine: An Atypical Antidepressant with Multimodal Pharmacology
Current Psychopharmacology Role of Nicotinic Acetylcholine Receptors in Cardiovascular Physiology and Pathophysiology: Current Trends and Perspectives
Current Vascular Pharmacology Editorial (Alcohol, Drugs, and Diving: Implications for Health and Fitness to Dive)
Current Drug Abuse Reviews